medlea-tech.com Description
MedLea offers proprietary technology that dramatically improves the functionality and performance of respiratory diagnostics and prognostics. Its solution solves the immediate need for detection and quantification of nodules, lesions, ventilation and perfusion. Currently, screening lungs is lengthy and error-prone resulting in 10% of missed early diagnostics, 25% less timely and accurate visits, 12% of wrong therapies. Medlea's high-throughput diagnostics cuts down response times by 90% with major benefits to diagnose stable and acute patients. It further anticipates exacerbations and forecast evolutions with major benefits to manage chronic conditions.
